Your browser doesn't support javascript.
loading
Impaired Physical Performance in X-linked Hypophosphatemia Is not Caused by Depleted Muscular Phosphate Stores.
Kara, Johannes Alexander Serhan; Zange, Jochen; Hoffman, Fabian; Tank, Jens; Jordan, Jens; Semler, Oliver; Schönau, Eckhard; Rittweger, Jörn; Seefried, Lothar.
Afiliação
  • Kara JAS; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Zange J; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Hoffman F; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Tank J; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Jordan J; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Semler O; Department of Pediatrics and Adolescent Medicine, University of Cologne, University Hospital Cologne, 50937 Cologne, Germany.
  • Schönau E; Department of Pediatrics and Adolescent Medicine, University of Cologne, University Hospital Cologne, 50937 Cologne, Germany.
  • Rittweger J; German Aerospace Center, Institute of Aerospace Medicine, 51147 Cologne, Germany.
  • Seefried L; Department of Pediatrics and Adolescent Medicine, University of Cologne, University Hospital Cologne, 50937 Cologne, Germany.
J Clin Endocrinol Metab ; 108(7): 1634-1645, 2023 06 16.
Article em En | MEDLINE | ID: mdl-37043477
ABSTRACT
CONTEXT X-linked hypophosphatemia (XLH) is a rare genetic disease, characterized by renal phosphate wasting and complex musculoskeletal manifestations including decreased physical performance.

OBJECTIVE:

To characterize muscular deficits in patients with XLH and investigate phosphate stores in muscles.

METHODS:

Case-control study (Muscle fatigability in X-linked Hypophosphatemia [MuXLiH]) with a 1-time assessment at the German Aerospace Center (DLR), Cologne, from May to December 2019, including patients with XLH cared for at the Osteology Department, University of Wuerzburg. Thirteen patients with XLH and 13 age/sex/body weight-matched controls aged 18-65 years were included. The main outcome measure was 31P-magnetic resonance spectroscopy (31P-MRS)-based assessment of phosphate metabolites in the soleus muscle at rest. Further analyses included magnetic resonance imaging-based muscle volume measurement, laboratory testing, isokinetic maximum voluntary contraction (MVC), fatigue testing, and jumping mechanography.

RESULTS:

By means of 31P-MRS, no significant differences were observed between XLH and controls regarding phosphate metabolites except for a slightly increased phosphocreatine to inorganic phosphate (PCr/Pi) ratio (XLH 13.44 ± 3.22, control 11.01 ± 2.62, P = .023). Quadriceps muscle volume was reduced in XLH (XLH 812.1 ± 309.0 mL, control 1391.1 ± 306.2 mv, P < .001). No significant differences were observed regarding isokinetic maximum torque (MVC) adjusted to quadriceps muscle volume. Jumping peak power and jump height were significantly reduced in XLH vs controls (both P < .001).

CONCLUSION:

The content of phosphoric compounds within the musculature of patients with XLH was not observed to be different from controls. Volume-adjusted muscle strength and fatiguability were not different either. Reduced physical performance in patients with XLH may result from long-term adaptation to reduced physical activity due to skeletal impairment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipofosfatemia / Raquitismo Hipofosfatêmico Familiar Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipofosfatemia / Raquitismo Hipofosfatêmico Familiar Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article